News – Page 996 – Endpoints News

On a roll, Vertex racks up impressive PhIII data for VX-659 combos in cystic fibrosis

7 years ago

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing

7 years ago

Newly named Abeona chief Carsten Thiel booted after the board accuses him of misconduct involving colleagues

7 years ago

Wellington, HBM lead €24M round as Adrenomed preps septic shock treatment for human testing

7 years ago

Global syndicate backs $400M genomics R&D play in Ireland as WuXi NextCODE extends its reach into Europe

7 years ago

Trump proposal tapers Medicare protection for certain drugs if drugmakers don't temper pricing

7 years ago

Shattering an old record, FDA quickly OKs pioneering, site-agnostic cancer drug larotrectinib from Loxo and Bayer

7 years ago

CheckMate-451: Bristol-Myers’ Opdivo — plus Yervoy — fails PhIII combo lung cancer study, the latest in a ...

7 years ago

Vivek Ramaswamy ramps up biotech startup #14 — this time working on a gene therapy for sickle cell disease and ...

7 years ago

GW Pharma shares surge on positive PhIII followup; Illumina leads $18M round for Stilla's DNA tech

7 years ago

After falling off a cliff, Edge Therapeutics provides cancer-focused PDS Biotech a reverse merger onto Nasdaq

7 years ago

Rolling up its sleeves, Axovant scoops up five gene therapy vets to propel new pipeline

7 years ago

Déjà vu for Zafgen: Still fretting about lingering cardio concerns, FDA clamps a hold on lead obesity drug -- ...

7 years ago

In a landmark first, Chinese scientist claims birth of genetically modified babies — and all hell breaks loose

7 years ago

Vectura sinks after PhIII asthma trial ends in failure, marking another setback

7 years ago

Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months

7 years ago

Roivant joins forces with Korea's iNtRON Bio to fight superbugs; Evotec inks deal to leverage AI to develop drugs

7 years ago

Pfizer wants to reel back contributions to Hyde-Smith after her remarks about ‘public hanging’ spark controversy

7 years ago

Roche ties up again with Ascletis — this time on a commercial partnership for hep B drug

7 years ago

Gurnet Point-backed Auregen taps Amgen vet to lead; Ex-Roche RNA chief takes CEO post at Genevant

7 years ago

Jury finds former Aveo CFO David Johnston liable for scheme to mislead investors

7 years ago

Novartis banks on the promise of digital therapeutics in the management of chronic disorders

7 years ago

Clozel hands over a rival to PTC’s controversial steroid deflazacort — now in a pivotal study for Duchenne MD

7 years ago

Sobi’s $50M bet on a rare disease drug pays off with a quick FDA nod

7 years ago

First page Previous page 993 994 995996997 998 999 Next page Last page